Download Docs
Export

BIOSYNTH

87069542 | Trademark

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Filed June 13, 2016
Serial No. 87069542
Registered Sept. 12, 2017
Registration No. 5,287,408
Class Medicinal preparations for photosensitizing agents used as a dermatologic drug or prodrug for the treatment of skin cancer by phototherapy; Chemical reagents for medical and veterinarian use; Chemical reagents for cultures of microorganisms for medical use, namely, in culture media for the isolation and identification of the bacteria strain Escherichia coli O157:H7; Chemical preparations for medical purposes, namely, for Cholesterol testing to prevent possible consequences of Hypercholesterolemia such as atherosclerosis, coronary heart disease and other forms of cardiovascular diseases; Chemical preparations for medical purposes, namely, for novel enzyme responsive inhibitors that allow for modifications of the composition of microbial communities; Chemical preparations for medical purposes, namely, for immunology research; Organic chemical preparations for medical purposes, namely, immunomodulatory compounds with anti-inflammatory properties; Organic chemical preparations for medical laboratory analysis purposes, namely, for medical detection, identification and quantification of strains of pathogenic bacteria; Chemical preparations for medical laboratory analysis purposes, namely, for medical immunological and microbiological blood testing; Chemical preparations for medical laboratory analysis purposes, namely, used as a routine medical supplement to blood culture media in vitro to inhibit blood coagulation and to improve the detection limits for individual microorganisms; Chemical preparations for medical laboratory analysis purposes, namely, for medical detection of pathogenic bacteria, namely, various strains of Listeria, Clostridium, Bacillus and Staphylococcus; Chemical preparations for medical laboratory analysis purposes, namely, for the medical detection and quantification of bacteria strains of Escherichia coli; Medical preparations for the diagnosis of Staphylococus aureus, in particular for Methicillin-resistant Staphylococcus aureus (MRSA); Medical enzyme; 006; 018; 044; 046; 051; 052
BIOSYNTH
Status A Sections 8 and 15 combined declaration has been accepted and acknowledged.
Last Updated: 4 months ago
Filing Date # Docket Text